Pharmafile Logo

Graduation day is celebrated by Lucid’s third Futures Academy cohort

- PMLiVE

Lucid’s Futures Academy is proud to release its most recent cohort of graduates into the business for the first of their two rotations.

The Futures Academy begins with an eight-week intensive course, aimed at equipping graduates with the skills needed for their careers in either account management or medical writing. The course, which began in January, covered a wide variety of topics, from general education about the pharmaceutical industry and its regulatory environment, to more specific tools for account management, medical writing and brand planning.

Elizabeth Hunt, one of this year’s cohort commented, “I think one great, and quite unique, aspect of the programme is the opportunity to see what is involved in both writing and accounts. A lot of people’s preferences change during their placements, so to have the chance to try both is really special and reflects Lucid’s willingness to make your job fit with you and your passions.”

Charlotte Monnickendam, another of this year’s graduates also said, “The programme gave us exposure to some of the industry’s finest people. From hiring external pharmaceutical marketing experts to spending valuable time with some of Lucid’s leaders. We are now in a good position to hone our skills to pursue our desired careers.”

The Futures Academy illustrates Lucid’s continual investment in bringing new talent to the industry. The programme reflects the human-centric spirit of the Lucid Group – individuals and teams working together to help nurture and build talent.

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Cultivating a learner-led culture: agile learning and the growth mindset

In this month’s Smart Thinking blog on PM.Live.com, Michelle Sweet, Learning and Development Consultant at Lucid Group, discusses the needs for a learner-led culture and a growth mindset in the...

Bluedog expands into the US with the appointment of George Pearson as Client Solutions Director

Bluedog, a Lucid Group Company, has elevated and expanded its creative team into the US with the appointment of George Pearson as Client Solutions Director.George is a highly experienced medical...

The inescapable rise of patient-centricity

The April issue of PME questions the meaning of ‘patient-centricity’ and whether we are achieving it.Patient-centricity has become a ubiquitous value within the pharmaceutical industry; however, is pharma delivering on...

Vivid welcomes magical new talent to the team

Vivid Medical Communications, a Lucid Group company, is delighted to announce two magical additions to the team.Deborah Blain joins Vivid as an Account Manager. With over 10 years’ experience in...

Easter Magic for Lucid Group

Lucid’s Futures Executives were set the challenge of planning a magical Easter surprise across its seven offices. After an egg-citing (sorry!) brainstorm the grads chose three activities.-    Egg-cellent Easter egg hunt-    You’re...

Lucid Group announces the appointment of new CFO

Lucid Group continues to build its infrastructure in line with its ambitious growth plans by appointing Michael Joyce as Chief Financial Officer (CFO).Michael has considerable experience as a CFO and...

Lucid Group Launch a Pioneering Leadership Programme for its Business Leaders

Great companies start with great leaders. However effective leadership requires skill, emotional intelligence, and most importantly, on-going self-improvement.With this in mind, Lucid Group has launched a new leadership programme for...

Leading Edge, a Lucid Group company, strengthens its senior client services team

Leading Edge, a Lucid Group company, is delighted to announce the appointment of its new Lead Client Partnership Director, Frances O’Connor.Frances is an experienced strategic healthcare communicator with expertise in...

From Cowgirl to Medical Writer – How did that happen?

Amy Jackson, Editorial Director, Lucid Group discusses her unlikely path into Medical Communications.

Measures for measures

Why pharma’s marketing metrics must close the loop